Online citations, reference lists, and bibliographies.
← Back to Search

Diagnostic And Therapeutic Strategy In Malignant Pleural Mesothelioma.

D. Branscheid, S. Krysa, E. Bauer, H. Bülzebruck, J. Schirren
Published 1991 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
We retrospectively analysed 301 patients with diffuse malignant pleural mesothelioma (235 male, 66 female; median age 59 years). Prognosis depended significantly on patient age, evidence of pain, loss of weight, tumour cell type, stage, local and distant metastasis, involvement of peritoneum and surgical treatment. The overall median survival rate was 238 days, after extended pleuropneumonectomy 284 days, and after decortication 315 days - significantly better than the prognosis in patients without surgical treatment or exploratory thoracotomy. Pleuropneumonectomy should only be considered in young patients with an epithelial cell-type tumour (possibly with adjuvant chemotherapy). Decortication seems nowadays to be the treatment of choice.



This paper is referenced by
10.21873/anticanres.13833
The mTOR Signaling Pathway Is Associated With the Prognosis of Malignant Pleural Mesothelioma After Multimodality Therapy
A. Kuroda (2019)
10.21037/jtd.2018.01.171
Treatment of malignant pleural mesothelioma: lessons learned and quo vadis?
S. Boeluekbas (2018)
10.1016/S1092-9134(00)90036-4
Mitotic and in situ end-labeling apoptotic indices as prognostic markers in malignant mesothelioma.
T. Beer (2000)
Scuola di Dottorato in Scienze Fisiopatologiche e neuropsicobiologiche e assistenziali del ciclo della vita - Ciclo XXVIII
Roberto Weinstein (2015)
Mesothelioma Interleukin 8 : An Autocrine Growth Factor for Malignant Updated
G. Gálffy (1999)
10.1016/j.jtcvs.2008.12.045
Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.
T. Yan (2009)
10.1053/j.semtcvs.2009.07.004
Multimodality strategies in malignant pleural mesothelioma.
W. Weder (2009)
10.1016/S0046-8177(98)90043-0
Prognosis in malignant mesothelioma related to MIB 1 proliferation index and histological subtype.
T. Beer (1998)
10.3390/jcm9072153
Should Lung-Sparing Surgery Be the Standard Procedure for Malignant Pleural Mesothelioma?
Y. Ichiki (2020)
10.1002/jso.25260
Short‐term outcomes of pleurectomy decortication and extrapleural pneumonectomy in mesothelioma
M. V. van Gerwen (2018)
10.5603/ARM.2019.0051
Current treatment strategies in malignant pleural mesothelioma with a treatment algorithm.
M. Sayan (2019)
10.1016/S1579-2129(06)70085-4
[Pleural mesothelioma: experience with 62 cases in 9 years].
V. Villena Garrido (2004)
10.1016/j.lungcan.2009.08.019
Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy.
S. Boeluekbas (2011)
10.1258/jrsm.2010.100345
A systematic review of lung-sparing extirpative surgery for pleural mesothelioma
Elaine S Teh (2011)
10.1007/978-3-662-12175-7_30
Das diffuse maligne Pleuramesotheliom
S. Krysa (1997)
10.1378/CHEST.109.5.1239
Treatment of malignant mesothelioma with methotrexate and vinblastine, with or without platinum chemotherapy.
K. Hunt (1996)
Interleukin 8: an autocrine growth factor for malignant mesothelioma.
G. Gálffy (1999)
10.1016/j.athoracsur.2014.09.056
Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma.
E. Taioli (2015)
10.2995/JACSURG.16.5_615
Results of surgical treatment for diffuse pleural mesothelioma
W. Nishio (2002)
Häufigkeit: Das Pleuramesotheliom ist der häufigste primäre Pleuratum­ or. Während es am Anfang des Jahrhunderts als ein sehr seltener Tumor galt, nimmt seine Häufigkeit in den letzten Jahrzehnten stark zu.
S. Krysa (1997)
10.1016/j.jtho.2018.08.001
Surgery in Malignant Pleural Mesothelioma
R. Bueno (2018)
10.3978/j.issn.2072-1439.2014.05.03
Management of malignant pleural mesothelioma-The European experience.
I. Opitz (2014)
10.1097/JTO.0000000000000055
PI3K/mTOR Signaling in Mesothelioma Patients Treated with Induction Chemotherapy Followed by Extrapleural Pneumonectomy
B. Bitanihirwe (2014)
10.1016/J.LUNGCAN.2004.11.003
Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary.
D. Maziak (2005)
10.1016/S1040-8428(96)00231-4
Malignant pleural mesothelioma.
H. Hoogsteden (1997)
10.1097/JTO.0b013e3181ed0489
A Systematic Review of Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma
C. Cao (2010)
10.1016/j.thorsurg.2016.04.003
Current Treatment of Mesothelioma: Extrapleural Pneumonectomy Versus Pleurectomy/Decortication.
A. Wolf (2016)
10.21037/JTD.2019.02.61
Extra-pleural pneumonectomy.
Leonardo Duranti (2019)
10.1007/s00104-012-2432-5
[Malignant pleural mesothelioma: comparison of radical pleurectomy und extrapleural pneumonectomy].
S. Boeluekbas (2013)
10.1097/JTO.0b013e31828353d7
Surgery in mesothelioma--where do we go after MARS?
B. Hiddinga (2013)
10.1016/B978-343723710-2.50056-1
Kapitel 52 – Techniken der Thoraxchirurgie
D. Branscheid (2006)
10.1007/s11748-018-1027-6
Updated meta-analysis of survival after extrapleural pneumonectomy versus pleurectomy/decortication in mesothelioma
D. Magouliotis (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar